Cargando…
Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.
Cancer is a worldwide public health concern. Identifying carcinogens and limiting their exposure is one approach to the problem of reducing risk. Currently, epidemiology and rodent bioassays are the means by which putative human carcinogens are identified. Both methods have intrinsic limitations: th...
Autores principales: | Tennant, R W, French, J E, Spalding, J W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519166/ https://www.ncbi.nlm.nih.gov/pubmed/8529591 |
Ejemplares similares
-
Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays.
por: Tennant, R W
Publicado: (1998) -
Predictions for the outcome of rodent carcinogenicity bioassays: identification of trans-species carcinogens and noncarcinogens.
por: Tennant, R W, et al.
Publicado: (1996) -
In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.
por: Contrera, J F, et al.
Publicado: (1998) -
Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
por: Matthews, E J, et al.
Publicado: (1993) -
Medium-term bioassays for carcinogenicity of chemical mixtures.
por: Ito, N, et al.
Publicado: (1998)